Suchergebnisse
Suchergebnisse:
Jeff Bornstein (born 17 April 1960; age 63) is an entertainer, actor, and occasional stuntman who performed stunts in Star Trek VI: The Undiscovered Country as an Excelsior crewmember. Bornstein was born in Van Nuys, Los Angeles, California and is a professional magician and comedian beside his occupation as an actor. He has also worked occasionally as a stuntman and stunt actor. Beside his ...
Bornstein brings over three decades of executive leadership experience, with significant focus on clean energy and global scale. EDISON, N.J., Sept. 09, 2022 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ: EOSE) (“Eos”), a leading provider of safe, scalable, efficient, and sustainable zinc-powered energy storage systems, today announced that Jeff Bornstein, former Chief Financial ...
I work well with all staff members, supervisors and outside contractors.<br><br>Look forward to hearing from you, thank you. Jeff · Experience: Public Health Institute · Location: San Francisco ...
- Public Health Institute
Our DMC Family sends its sincere condolences to the entire Bornstein Family on the passing of DMC club member Jeff Bornstein’s Dad ..R.I.P. Matt Bornstein. .. 118. 40 comments.
Jeff Bornstein joined Mediar as the CMO in July of 2023, after a drug development career spanning more than 20 years. He was part of the team at Elan that helped launch Tysabri and part of the liver development group at Gilead that launched Sovaldi. At Gilead, he had the opportunity to lead the development of several anti-fibrotic agents in liver indications including NASH and PSC. Jeff did ...
6. Okt. 2017 · General Electric said on Friday that chief financial officer and vice-chairman Jeff Bornstein, once considered a contender to succeed former chief executive Jeffrey Immelt, is leaving the company ...
15. März 2021 · Jeff Bornstein, M.D. to serve as Chief Medical Officer and Paul Little as Chief Financial Officer. IRVINE, Calif., March 15, 2021 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a clinical stage biopharmaceutical company focused on developing life-changing, targeted medicines for persons undergoing organ or cellular transplantation, as well as those living with ...
